Currently out of the existing stock ratings of Sean Lee, 56 are a BUY (90.32%), 6 are a HOLD (9.68%).

Sean Lee

Work Performance Price Targets & Ratings Chart

Analyst Sean Lee, carries an average stock price target met ratio of 30.28% that have a potential upside of 48.2% achieved within 91 days. Previously, Sean Lee worked at HCWAINWRIGHT.

Sean Lee’s has documented 117 price targets and ratings displayed on 11 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ATEC, Alphatec Holdings at 14-Jan-2025.

Wall Street Analyst Sean Lee

Analyst best performing recommendations are on CTSO (CYTOSORBENTS CRP).
The best stock recommendation documented was for CTSO (CYTOSORBENTS CRP) at 11/11/2024. The price target of $1 was fulfilled within 1 day with a profit of $0.16 (19.05%) receiving and performance score of 190.48.

Average potential price target upside

CASI CASI Pharmaceuticals CTSO Cytosorbents Crp GRTS Gritstone Oncology ATEC Alphatec Holdings KT KT KZIA Kazia Therapeutics Ltd ADR MNPR Monopar Therapeutics PSTV Plus Therapeutics THMO Thermogenesis Holdings VIRI Virios Therapeutics Llc VSTM Verastem

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$6

$3.38 (129.01%)

$12

8 months 6 days ago
(15-May-2024)

1/4 (25%)

$2.73 (83.49%)

54

Buy

$4

2 years 2 months 5 days ago
(16-Nov-2022)

1/2 (50%)

$0.72 (21.95%)

73

Buy

$12

$9.38 (358.02%)

2 years 5 months 6 days ago
(15-Aug-2022)

1/2 (50%)

$7.98 (198.51%)

308

Buy

$50

2 years 7 months 26 days ago
(26-May-2022)

0/1 (0%)

$32.3 (182.49%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Sean Lee is most bullish on?

Potential upside of $8.43 has been obtained for ATEC (ALPHATEC HOLDINGS)

Which stock is Sean Lee is most reserved on?

Potential downside of -$6.54 has been obtained for MNPR (MONOPAR THERAPEUTICS)

What Year was the first public recommendation made by Sean Lee?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?